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Abstract
Background: Multidrug-resistant Salmonella strains are frequently encountered problems worldwide with
considerable increased occurrences in recent years. The aim of this study was to investigate the occurrence and
frequency of antimicrobial resistance and associated resistance genes in Salmonella isolates from broiler farms in
different regions of Iran covering a time period of four years.
Results: From 2007 to 2011, 36 Salmonella strains were isolated from broiler farms located in three northern
provinces of Iran. The isolates were serotyped, antimicrobial susceptibility tested, and characterized for antimicrobial
resistance genes associated to the phenotype. Pulsed-field gel electrophoresis (PFGE) was applied for comparison of
genetic relatedness.
Two serovars were detected among the isolates; Salmonella enterica serovar Infantis (75%) and S. Enteritidis (25%).
Thirty-four (94%) of the isolates exhibited resistance to nalidixic acid and ciprofloxacin caused by a single mutation
in the quinolone resistance-determining region (QRDR) of gyrA. For all strains this mutation occurred in the codon
of Asp87 leading to a Asp87-Tyr, Asp87-Gly or Asp87-Asn substitutions. All S. Infantis (n = 27) were resistant to
tetracycline, spectinomycin, streptomycin, and sulfamethoxazole and harbored the associated resistance genes; tetA,
dfrA14, aadA1, and sulI together with class 1 integrons. The isolates revealed highly similar PFGE patterns indicating
clonal relatedness across different geographical locations.
Conclusion: The data provided fundamental information applicable when launching future control programs for
broilers in Iran with the aim to conserve the effectiveness of important antimicrobials for treatment in humans.
Keywords: Salmonella infantis, Salmonella enteritidis, Antimicrobial resistance, MIC determination, Resistance gene,
PFGE, Fluoroquinolone, Poultry, Iran
Background
Salmonellosis is one of the most important diseases in
both humans and animals and has been described as the
second most common cause of foodborne bacterial
human disease worldwide [1]. It is estimated that 93.8
million cases of gastroenteritis due to Salmonella spp.
occur annually worldwide leading to 155,000 deaths
each year [2]. A significant increase in the number of
Salmonella infections has been observed in many coun-
tries over the past decade [3]. Globally, the most prevalent
serovars in humans are Salmonella enterica serovars
Typhimurium and Enteritidis [4].
Chicken and related products are recognized as import-
ant reservoirs for Salmonella and vehicles for salmonel-
losis. Some Salmonella serovars such as S. Enteritidis, S.
Infantis, S. Kentucky, and S. Heidelberg appear to be more
prevalent in poultry than in other food animals [5].
Widespread use of antimicrobial agents in food animal
production has contributed to the occurrence in animals
of resistant zoonotic pathogens such as Salmonella. Whilst
antimicrobial resistance is moderate in the predominant
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poultry-related serovar; S. Enteritidis [5,6], multidrug
resistance (MDR) is frequent in other Salmonella serovars
[6]. In poultry production, antimicrobial agents are
widely used for growth promotion, prophylaxis or treat-
ment purposes [7,8]. As a consequence, chicken and
chicken meat can harbor antimicrobial resistant strains
and function as a vehicle for dissemination of these to
humans. Today, MDR Salmonella strains are frequently
encountered in most of the world and the rates of MDR
have increased considerably in recent years [9]. As a
result, extended-spectrum cephalosporins (ESC) and
fluoroquinolones (FQ) are the drugs of choice for treat-
ment of severe Salmonella infections. Accordingly,
limiting the occurrence of resistance to ESC and FQ is a
public health priority and these drugs have been classi-
fied by the World Health Organization as critically im-
portant antimicrobials [10]. The resistance mechanisms
responsible for the increase in antimicrobial resistance
are mainly a result of the horizontal gene transfer via mo-
bile genetics elements such as plasmids and integrons.
The strong association between MDR Salmonella and the
presence of integrons; especially class 1, has been well
documented [11]. To embark on and enforce prevention
and control measurements, it is vital to elucidate and
understand the global epidemiology of antimicrobial
resistance pheno- and genotypes [12]. In recent years,
MDR bacterial pathogens have emerged and disseminated
in Iran and have become a challenging problem for the
medical and veterinary community. Unfortunately, studies
revealing the frequency of antimicrobial resistance and
corresponding genes in pathogens of poultry origin are
sparse. Poultry is one of the predominant reservoirs for
Salmonella in Iran and in the Iranian poultry sector
production infrastructure has progressed rapidly in recent
years, especially in the northern part of the country.
In this study, the objectives were to investigate the
occurrence and frequency of antimicrobial resistance and
associated resistance genes in Salmonella isolates from
broilers originating from farms located in three northern
provinces of Iran in the period from 2007 to 2011 with
the application of minimal inhibitory concentration (MIC)
determination and polymerase chain reaction (PCR). To
elucidate if any genotypes were predominating among the
isolates, mechanisms for FQ resistance were investigated
by subsequent sequencing of PCR amplicons. Addition-
ally, we utilized pulsed-field gel electrophoresis (PFGE)
and MIC patterns to determine the clonal relatedness and
to elucidate any epidemiological links between the farms
and in a temporal context.
Methods
Bacterial isolates
A total of 36 broiler-related Salmonella isolates cover-
ing a four-year period, from 2007 to 2011, were included
in this study. The isolates originated from 14 different
broiler farms situated in the northern provinces of
Mazandaran, Guilan, and Golestan in Iran. The capacity
of the farms ranged from 5,000 to 18,000 broilers per
house. Samples taken included fresh randomly collected
feces, cloacal feces and a limited number of carcasses at
8 to 49 days old. A randomized convenience sampling
was employed and collection, isolation, and identification
of Salmonella spp. were conducted according to standard
procedures [13].
Serotyping, antimicrobial susceptibility testing, and
pulsed-field gel electrophoresis
The procedures for serotyping and PFGE of the isolates
included in this study have been described previously
[14]. In brief, all isolates were serotyped using slide
agglutination and assigned a serotype according to the
Kauffmann-White scheme [15]. In addition, all isolates
were genotyped by PFGE using XbaI according to the
CDC PulseNet protocol [16].
MIC determination was performed using a commer-
cially prepared, dehydrated panel, Sensititre, from TREK
Diagnostic Systems Ltd. The antimicrobials used and
interpretative criteria applied were as follows: ampicillin,
AMP (R > 8 mg/L); amoxicillin + clavulanic acid, AUG
(R ≥ 32 mg/L); apramycin, APR (R > 32 mg/L); cefotaxime,
FOT (R > 0.5 mg/L); ceftiofur, XNL (R > 2 mg/L); chlor-
amphenicol, CHL (R > 16 mg/L); ciprofloxacin, CIP
(R-low level: 0.064 to 1 mg/L, and R-high level > 1 mg/L);
colistin COL (R > 2 mg/L); florfenicol, FFN (R > 16 mg/L);
gentamicin, GEN (R > 2 mg/L); nalidixic acid, NAL
(R > 16 mg/L); neomycin, NEO (R > 4 mg/L); spectino-
mycin, SPE (R > 64 mg/L); streptomycin, STR (R >
16 mg/L); sulfamethoxazole, SMX (R > 256 mg/L);
tetracycline, TET (R > 8 mg/L); and trimethoprim,
TMP (R > 2 mg/L). For interpretation of antimicrobial
susceptibility test results epidemiological cut-off values
according to EUCAST recommendations [17] were ap-
plied for all antimicrobials except APR, AUG, SMX,
and SPE for which EUCAST values are not available to
date. For AUG, SMX and SPE clinical breakpoints
according to the Clinical and Laboratory Standards
Institute (CLSI) were applied [18-20] and for APR the
interpretation was based on research results from DTU
Food due to the lack of a CLSI clinical breakpoint.
Reference strain E. coli ATCC 25922 was used as a
Quality Control according to CLSI standards [18-20].
Screening for resistance genes and integrons
All isolates exhibiting phenotypic resistance to either of
the tested antimicrobials were characterized for the
presence of associated antimicrobial resistance genes.
Isolates resistant to sulfamethoxazole (all S. Infantis)
were screened for class 1 and 2 integrons using a PCR
Rahmani et al. BMC Veterinary Research 2013, 9:66 Page 2 of 9
http://www.biomedcentral.com/1746-6148/9/66
assay with specific primers. The PCR reactions were
performed according to previously described conditions
[21]. In brief, three different PCR reactions were
performed utilizing the following primers: qacEΔ1-F/
qacEΔ1-B targeting qacEΔ1, SulIB/qacEΔ1-F targe-
ting the sulI and qacEΔ1 region, and IntI1 variable-B
targeting the variable region of class 1 integrons.
For class 2 integrons, two PCR reactions were used
targeting the conserved and the variable region, respect-
ively. Target genes, sequences, annealing temperature,
amplicon sizes, and references of all PCR tests are listed
in Table 1.
Table 1 Primer sequences used for the amplification of the various resistance genes
Target genes Sequence (5' to 3') Annealing temp Size (bp) Reference
tetA 5'-GTAATTCTGAGCACTGTCGC-3' 57 950 [22]
5'-CTGCCTGGACAACATTGCTT-3'
tetB 5'-CTCAGTATTCCAAGCCTTTG-3' 52 430 [23]
5'-ACTCCCCTGAGCTTGAGGGG-3'
tetC 5'-GGTTGAAGGCTCTCAAGGGC-3' 62 505 [23]
5'-CCTCTTGCGGGATATCGTCC-3'
tetD 5'-CATCCATCCGGAAGTGATAGC-3' 57 435 [24]
5'-GGATATCTCACCGCATCTGC-3'
tetG 5'-GCAGCGAAAGCGTATTTGCG-3' 62 680 [25]
5'-TCCGAAAGCTGTCCAAGCAT-3'
aadA 5'-ATTTGCTGGTTACGGTGACC-3' 56 533 [21]
5'-CTTCAAGTATGACGGGCTGA-3'
strA 5'-CCAATCGCAGATAGAAGGC-3' 55 500 [26]
5'-CTTGGTGATAACGGCAATTC-3'
strB 5'-GGATCGTAGAACATATTGGC-3' 56 500 [26]
5'-ATCGTCAAGGGATTGAAACC-3'
dfrA14 5'-TGAGAACCTTGAAAGTATCATTG-3' 55 483 This study
5'-ACCCTTTTTCCAAATTTGATAG-3'
florR 5'-ATGGCAGGCGATATTCATTA-3' 55 320 This study
5'-AAACGGGTTGTCACGATCAT-3'
sulII 5'-GCGCTCAAGGCAGATGGCATT-3' 70 284 [26]
5'-GCGTTTGATACCGGCACCCGT-3'
sul1/qacEΔ1I 5'-ATCGCAATAGTTGGCGAAGT-3' 58 798 [22]
5'-GCAAGGCGGAAACCCGCGCC-3
sulI 5'-TGAGATCAGACGTATTGCGC-3' 58 420 This study
5'-TTGAAGGTTCGACAGCACGT-3'
qacEΔ1 5'-ATCGCAATAGTTGGCGAAGT-3' 57 226 [22]
5'-CAAGCTTTTGCCCATGAAGC–3'
IntI1 5'-AAGCAGACTTGACCTGAT-3' 55 Variable [22]
5'-GGCATCCAAGCAGCAAGC-3'
IntI2 5'-CACGGATATGCGACAAAAAGGT-3' 60 789 [27]
5'-GTAGCAAACGAGTGACGAAATG-3'
IntI2 variable 5'-GACGGCATGCACGATTTGTA-3' 56 2214 [28]
5'-GATGCCATCGCAAGTACGAG-3'
gyrA 5'-TACCGTCATAGTTATCCACGA-3' 60 312 [29]
5'-GTACTTTACGCCATGAACGT-3'
parC 5'-CTATGCGATGTCAGAGCTGG-3' 59 261 [29]
5'-TAACAGCAGCTCGGCGTATT-3'
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All isolates resistant to nalidixic acid and ciprofloxacin
(all isolates included in this study with the exception of
two S. Enteritidis) were tested by PCR amplification to
detect possible chromosomal mutations in DNA gyrase
(gyrA) and topoisomerase IV (parC). Amplicons of the
genes gyrA and parC were purified using the GFX™ PCR
DNA kit (Amersham Biosciences, Piscataway, New
Jersey, US) and one sample of each serotype per farm
was shipped to Macrogen Inc., South Korea for sequen-
cing using the same forward primers as used in the PCR
analysis. Vector NTI suite 11 (InforMax, Inc.) software
(Bethesda, Maryland, US) was used for sequencing ana-
lysis and alignment. The resulting nucleotide sequences
were compared to the corresponding sequences obtained
from GenBank [30].
Results
Serotyping
Twenty-seven (75%) out of 36 isolates were typed as S.
Infantis whereas the remaining isolates were S. Enteritidis
(25%, n = 9). The distribution of S. Infantis in each
province was 90%, 82%, and 50% in Mazandaran,
Golestan, and Guilan, respectively, whereas the distribu-
tion of S. Enteritidis was 50%, 18%, and 10% in Guilan,
Golestan, and Mazandaran, respectively.
Antimicrobial susceptibility testing
Thirty-four out of 36 isolates tested were resistant to at
least two antimicrobial agents out of 17 agents tested
(Figures 1 and 2). Two (5.5%) S. Enteritidis isolates from
the same province were susceptible to all tested anti-
microbial agents (Figure 2). The highest frequency
(94%, n = 34) of antimicrobial resistance was observed
to nalidixic acid and ciprofloxacin (Figures 1 and 2). Of
the serovars identified in this study, S. Enteritidis
showed less resistance to antimicrobial agents compared
to S. Infantis. Of 27 S. Infantis isolates, all were resistant
to ciprofloxacin, nalidixic acid, tetracycline, spectino-
mycin, streptomycin, sulfamethoxazole. In addition,
17 (63.0%) were resistant to trimethoprim, and one
(3.7%) was resistant to florfenicol and chloramphenicol
(Figure 1).
Figure 1 PFGE pattern of Salmonella serovar Infantis isolated from three Northern provinces of Iran. Footnotes: Black squares represent
the isolates classified as resistant, Abbreviations: AMP, Ampicillin; AUG, amoxicillin + clavulanic acid; APR, apramycin; FOT, cefotaxime; XNL,
ceftiofur; CHL, chloramphenicol; CIP, ciprofloxacin; COL, colistin; FFN, florfenicol; GEN, gentamicin; NAL, nalidixic acid; NEO, neomycin; SPE,
spectinomycin; STR, streptomycin; SMX, sulfamethoxazole; TET, tetracycline; TMP, trimethoprim.
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Screening for resistance genes and integrons
Out of twenty-seven S. Infantis isolates from three prov-
inces, all (100%) harbored the intl genes confirming the
presence of class 1 integrons but none of the S. Enteritidis
were positive for integron class 1. The S. Infantis isolates
were resistant to six or more antimicrobial agents
(Figure 1). Seventeen (62.9%) of the S. Infantis isolates
from the provinces of Golestan and Mazandaran carrying
the class 1 integron also harbored the class 2 integron,
however, the PCR result for the detection of the variable
region in integron class 2 was negative. We confirmed the
presence of IntI in two isolates (#248 and #Z6) by nucleo-
tide sequence comparison with that of an Escherichia coli
strain (GenBank accession no. AU780012) from position
1038 to 1785 and found 100% similarity. Among the genes
conferring resistance to tetracycline, 27 of S. Infantis iso-
lates originating from all three provinces carried the tetA
gene. However, none of S. Infantis isolates contained tetB,
tetC, tetD, and tetG genes. In addition, no S. Infantis iso-
lates were positive for the presence of sulII. S. Infantis iso-
lates that were tested for the presence of strA, strB and
aadA1 genes, were positive for aadA1 only. In addition,
one S. Infantis isolate (2.7%) from Mazandaran province
was found positive for floR. Twenty-two (61.1%) S. Infantis
isolates from the provinces of Golestan and Mazandaran
harbored the dfrA14 conferring resistance to trimetho-
prim whereas only one (2.7%) S. Enteritidis isolate was
positive for dfrA14. The detailed data of all isolates and
PCR results for detected genes are shown in Table 2.
Twenty-one (61.7%) out of 34 isolates that were resist-
ant to nalidixic acid and ciprofloxacin were selected for
sequencing and detection of point mutations in the
Quinolone Resistance Determining Region (QRDR) of
gyrA and parC genes. All of the detected single muta-
tions occurred in codon Asp87 of the gyrA gene. Substi-
tution of Asp-Tyr, Asp-Gly, and Asp-Asn were observed
in 13 S. Infantis (61.9%), one S. Enteritidis (4.8%), and
seven S. Infantis (33.3%) isolates, respectively. No
double mutations were found in the gyrA gene of
the tested isolates and no mutations were identified in
the parC gene of any of the isolates.
Pulsed-field gel electrophoresis
Salmonella Infantis
Two distinct PFGE patterns were observed among the 27
S. Infantis isolates (Figure 1). All but one isolate clustered
Figure 2 PFGE pattern of Salmonella serovar Enteritidis isolated from three Northern provinces of Iran. Footnotes: Black squares
represent the isolates classified as resistant, Abbreviations: AMP, Ampicillin; AUG, amoxicillin + clavulanic acid; APR, apramycin; FOT, cefotaxime;
XNL, ceftiofur; CHL, chloramphenicol; CIP, ciprofloxacin; COL, colistin; FFN, florfenicol; GEN, gentamicin; NAL, nalidixic acid; NEO, neomycin; SPE,
spectinomycin; STR, streptomycin; SMX, sulfamethoxazole; TET, tetracycline; TMP, trimethoprim.
Table 2 Distribution of antimicrobial resistance genes of Salmonella isolates originating from poultry in three Northern
provinces of Iran
Province No. of isolates Serotype No. and (%) of isolates with antimicrobial resistance genes
floR tetA aadA1 dfrA14 sulI Int1 Int2
Golestan 13 S. Infantis 0 13 (81) 13 (81) 12 (75) 13 (81) 13 (81) 12 (75)
3 S. Enteritidis 0 0 0 0 0 0 0
Mazandaran 9 S. Infantis 1 (10) 9 (90) 9 (90) 5 (50) 9 (90) 9 (90) 5 (50)
1 S. Enteritidis 0 0 0 0 0 0 0
Guilan 5 S. Infantis 0 5 (50) 5 (50) 0 5 (50) 5 (50) 0
5 S. Enteritidis 0 0 0 1 (10) 0 0 0
Total 36 1 (3) 27 (75) 27 (75) 18 (50) 27 (75) 27 (75) 17 (47)
All isolates were negative for detection of tetB, tetC, tetG, strA, strB and sulII resistance genes.
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within a unique pattern covering all three provinces and
the full extent of the tested time period. Sixteen of the
indistinguishable isolates within the unique cluster were
from the provinces of Golestan and Mazandaran and iso-
lated in 2007 and 2011. Additionally, all of those isolates
conferred resistance to the same seven antimicrobials
including ciprofloxacin and nalidixic acid (Figure 1). All
but one of the remaining ten identical isolates of the
unique cluster were isolated in 2011, whereas one isolate
was from 2007. The ten isolates were from the province of
Golestan (n = 1), Mazandaran (n = 4), and Guilan (n = 5)
and all shared the same antimicrobial resistance pattern of
six antimicrobials. One isolate; #Z10 from the province of
Mazandaran, demonstrated a unique PFGE and resistance
profile compared to the other 26 isolates included this
study (Figure 1).
Salmonella enteritidis
Two clusters were defined for the nine S. Enteritidis cover-
ing all three provinces and the full extent of the tested
time period (Figure 2). One unique pattern comprised
seven isolates from all three provinces whereas the second
pattern only included two strains from the province of
Golestan isolated in 2008 (Figure 2). All nine isolates rep-
resented resistance profiles of resistance to ciprofloxacin
and nalidixic acid and two isolates additionally conferred
resistance to colistin (#262, Golestan) and trimethoprim
(#M10, Mazandaran) (Figure 2).
Discussion
Currently, increasing bacterial resistance to antimicro-
bial agents including quinolones and FQ poses a serious
problem throughout the world. To date, several reports
from Iran have described the presence of resistance to
antimicrobial agents such as FQ and third-generation
cephalosporins that are critically important for treatment
of infections in humans [31,32].
The widespread overuse and misuse of antimicrobial
agents are associated with the development of resistance
to these drugs that has emerged as a major problem
worldwide. In Iran, patients referred to hospitals with
Salmonella infections are usually treated with ciproflox-
acin, co-amoxiclav (amoxicillin + clavulanic acid) or
cephalosporins [31]. Quinolones and especially FQ are
widely used in poultry farms in Iran [33], for example,
enrofloxacin, which is chemically closely related to
norfloxacin and ciprofloxacin, is one of the antimicro-
bials most frequently used for the treatment of poultry.
Except for a few antimicrobials such as bacitracin and
virginamycin, the use of antimicrobials for growth pro-
motion is illegal in Iran, however, one could speculate if
growth promotion in some cases might still take place.
This might explain the high frequency of resistance to
FQ in this study. Unfortunately, there is no surveillance
or control system to monitor the prudent use of antimi-
crobials in the agricultural sector.
A high frequency of resistance to ciprofloxacin and
nalidixic acid in S. Enteritidis and S. Infantis isolated from
different regions over time within Iran was found in this
study. This correlates with several studies performed in
Iran where Morshed and Peighambari [34] observed
high levels of resistance to nalidixic acid (24.1%) and
enrofloxacin (6.9%) among Salmonella isolated from
poultry. In comparison, they found lower frequencies of
resistance to other antimicrobial drug classes. Rad et al.
[33] reported 40% and 23% resistance to nalidixic acid
and enrofloxacin, respectively, in Salmonella isolates
of animal origin. The high resistance rate (94%) to
quinolones observed in this study might indicate
common use of enrofloxacin for various reasons during
the past decade in veterinary medicine in Iran.
As in the present study, resistance to streptomycin,
spectinomycin, tetracycline, trimethoprim, and sulfa-
methoxazole have also frequently been reported in other
studies on poultry products [34-36]. The very low rate of
resistance to chloramphenicol among the studied isolates
(one S. Infantis) may be attributed to its banned use in
animal production due to the potential hazards to human
consumers’ health. In addition, we observed no cephalo-
sporin resistance among the studied isolates which is
valuable to the community as cephalosporin resistance is a
serious public health concern.
Increased MDR has been reported in Salmonella iso-
lates in many countries including Iran [31,37]. The high
level of MDR observed among S. Infantis is in agreement
with several studies from different countries which have
identified healthy poultry as a potential reservoir of S.
Infantis [35,36,38].
Furthermore, several studies documented the presence
of large plasmids in S. Infantis carrying antimicrobial
resistance (AMR) determinants. Kehrenberg et al. [39]
reported transferable plasmid mediated fluoroquinolone
resistance (qnrS1) in S. Infantis isolates from broilers in
Germany. Gal-More et al. and Nogrady et al. [40,41]
showed multidrug resistant emerging clones characterized
by a large conjugative plasmid harboring the Tn1721
transposon, including the tetA gene.
In contrast, S. Enteritidis was less prone to acquiring
resistances than other serotypes as described previously
in Spain and other countries [6].
In this study, we describe the presence of class 1 and 2
integrons only attributed to S. Infantis. Isolates containing
class 1 integrons all conferred resistance to sulfonamides
and harbored the sulI resistance gene. Additionally, all
antimicrobial resistance phenotypes harbored the follow-
ing associated resistance genes: streptomycin (aadA1),
trimethoprim (dfrA14), florfenicol (floR), and tetracyclines
(tetA). The relationship between the application of
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quinolones and the dissemination of bacterial resistance
from animals to humans has been described by several
studies [42,43]. The results obtained in the current study
could be related to those obtained by Tajbakhsh et al. [31]
who described Iranian patients infected with S. Infantis
which were resistant to the same antimicrobial agents and
harbored the same resistance determinants as described in
this study [31].
Presently, we are in a transition phase where next
generation sequencing (NGS) technology is introduced
for prediction of resistance phenotypes. Hence, linking
resistance genes with resistance phenotypes will be more
and more important for the understanding of why some
isolates are extremely resistant and why some contain
multiple resistance genes encoding resistance to the
same antimicrobial classes. Recently, a study described
extremely resistant Salmonella Senftenberg isolates
harboring an arsenal of resistance genes detected by
NGS and the use of a resistance database [44,45]. Many
questions are still left unanswered, for example how
much each of the genes affects the overall MIC value for
the specific antimicrobial class.
Seventeen of the S. Infantis isolates also harbored class 2
integrons. For those isolates, the primers utilized for the
variable region did not amplify any DNA fragment. This is
probably due to not previously observed variations or
large insertion in the variable region. Overall, the presence
of integrons indicates the important role of those in
disseminating resistance determinants in S. Infantis. Add-
itionally, this indicates a possible spread of the resistant S.
Infantis isolates from poultry to humans. Unfortunately,
PFGE was not applied in the study of Tajbakhsh et al. why
a comparison of PFGE profiles could not be conducted to
determine the genetic relatedness.
The serovars of this study predominantly belonged to
S. Infantis followed by S. Enteritidis. EFSA and ECDC
[46] have considered S. Infantis as the third most common
serovar in European patients since 2006 with an increase
from 1.0% to 1.6% in 2009 in the European Union (EU).
Additionally, the same trend has been observed globally,
where the overall proportion of S. Infantis over the years
2001 to 2007 increased from 1.5% to 2.2% [4]. Likewise,
chicken meat has been acknowledged as a significant
source of S. Infantis transmitting the infection to
humans [47]. To the best of our knowledge; this is the
first study that links S. Infantis to poultry in Iran. How-
ever, there are several reports in human medicine
indicating that S. Infantis is an important contributor to
human salmonellosis. Hamidian et al. [32] found 20.9%
S. Enteritidis and 5.4% S. Infantis from 129 Salmonella
isolated from humans in Tehran. In addition, the
highest level of resistance was observed to nalidixic acid
whereas no resistance to ciprofloxacin was observed.
The absence of resistance to ciprofloxacin in previous
reports most likely reflects the interpretative criteria
applied.
All sequenced isolates resistant to nalidixic acid and
ciprofloxacin presented a single-mutation in Quinolone
Resistance-Determining Regions of gyrA in codon 87.
The percentage of strains with mutation in codon 87 is
consistent with studies done by San Martin et al. and
Liebana et al. [48,49].
No mutation was detected in parC-genes. The high
prevalence of S. Infantis in this study may suggest an out-
come of a clonal expansion and establishment of specific
PFGE biotypes of S. Infantis. Possibly, S. Infantis has
developed mechanisms protecting the serovar from major
genetic rearrangements or horizontal genetic transfers.
Another explanation could be that the serovar has a recent
ancestor and therefore broad dissemination has not yet
been possible of the limited number of accumulated major
evolutionary changes at this point of time [35].
Based on PFGE, indistinguishable patterns were ob-
served among S. Enteritidis. The lack of genetic diversity
observed for S. Enteritidis as determined by PFGE is
also shown in previous studies that confirm this sero-
type as highly clonal [50]. PFGE was of limited value in
the epidemiological analysis of these particular isolates,
however, this may actually be a reflection of the restricted
clonal diversity of pathogenic strains of S. Enteritidis [51].
Lack of inclusive studies about serotypes distribution, anti-
microbial resistance pattern and molecular investigation
of poultry isolates in Iran, make this study unable to ob-
tain confirmatory comparisons of the results. The limi-
tations of this study include a confined geographical
coverage and limited number of isolates as well as an
overall comparison approach that did not include an in-
depth molecular characterization of plasmids etc. The
combined effect of these is reflected in the research out-
put and it is therefore suggested that future research
should take these limitation into consideration when
characterizing S. Infantis in both humans and poultry.
Conclusion
The study revealed a high frequency of resistant S. Infantis
in broilers farmed in three different geographical areas
between 2007 and 2011. The isolates especially exhibited
resistance to nalidixic acid and ciprofloxacin caused by a
point mutation in QRDR of gyrA. Additionally, the isolates
harbored class 1 and 2 integrons and contained the
aadA1, sulI, tetA, and dfrA14 resistance genes. This may
suggest widespread misuse or overuse of antimicrobial
agents by poultry farmers in Iran. However, the results
obtained from serotyping and PFGE patterns are practical
for determining the current distribution of MDR serovars
of Salmonella and epidemiological state of Salmonella
isolates circulating among poultry. This study showed that
guidelines are needed in Iran for empiric antibacterial
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therapy based on a local experience of antimicrobial
susceptibility testing and restriction of antimicrobial
growth promoters and other drugs used without pre-
scription in animals. In addition, the data presented in
this study provided valuable fundamental information
for future national control programs in Iran to conserve
the effectiveness of medically important antimicrobials
for treating diseases in humans.
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